Clinical Trial Update: A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors [Phase 1]

View source ↗

Summary

This is a completed Phase 1 pilot study evaluating treatment for patients with metastatic and high-risk sarcomas and primitive neuroectodermal tumors. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma
• Primitive Neuroectodermal Tumor
• Soft Tissue Sarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neuroectodermal Tumor, Primitive, Neuroepithelioma | Phase 1 | Status: COMPLETED